Portolan Capital Management’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-15,338
Closed -$4.81M 118
2023
Q4
$4.81M Buy
+15,338
New +$5.55M 0.42% 79
2022
Q4
Sell
-7,432
Closed -$4.35M 133
2022
Q3
$4.35M Buy
+7,432
New +$4.45M 0.46% 80

Other funds holding AGL

Portolan Capital Management's AGL Position: Q1 2024 in Review

Portolan Capital Management sold out of Agilon Health (AGL) in Q1 2024, closing a stake of 15,338 shares — an estimated $4.81M sold.

Portolan Capital Management first reported a position in AGL in Q3 2022 and held it in 2 quarters. The position peaked at $4.81M in Q4 2023. 198 funds tracked by Wall St. Rank hold AGL as of Q1 2024.

  • Portolan Capital Management reported no remaining Agilon Health position as of Q1 2024 after selling out during the quarter.
  • Portolan Capital Management sold 15,338 Agilon Health shares in Q1 2024, an estimated $4.81M.
  • Portolan Capital Management first reported a position in Agilon Health in Q3 2022 and held it in 2 quarters.
  • Portolan Capital Management's Agilon Health position peaked at $4.81M in Q4 2023.
  • 198 funds tracked by Wall St. Rank held Agilon Health as of Q1 2024.

Based on Portolan Capital Management's 13F filing for Q1 2024, filed 15 May 2024.